The $18.5 million grant will help researchers at USC Norris Comprehensive Cancer Center close the gap in understanding colorectal cancer in Hispanic patients.
Findings from a new study could point the way to new treatments for blood diseases including cancers such as leukemia and lymphoma.
The USC study also underscored a major problem facing cancer researchers: studying non-representative samples of patient cells.
Work from scientists led by USC’s Oliver Bell and a colleague could counteract the effects of mutated epigenetic regulators, which are known to drive certain types of cancer including lymphoma.
A global clinical trial will assess the new therapy, which combines a monoclonal antibody and anti-cancer medication to deliver targeted doses directly to the tumor cells.
With women’s health in mind, USC experts explain why screenings and yearly preventive visits are essential and who may need additional testing offered.
The USC study’s findings are important because they may predict where a specific cancer may spread in the brain, and may also have implications for how brain tumors grow.
As chair of the presidential board, Carpten will be in a position to guide the nation’s cancer research efforts.
USC research indicates that those most at risk of hepatocellular carcinoma are men ages 60-69, non-Hispanic Blacks, American Indian/Alaskan Natives and residents of high-poverty areas.
USC Viterbi doctoral student researchers have found a new way to enhance the cancer-killing properties of CAR T-cell therapies, which makes them more effective in fighting tumors.
Children genetically predisposed to overproduce lymphocytes in relation to other white blood cells are at higher risk of developing acute lymphoblastic leukemia, according to USC research.
Hispanic and non-Hispanic Black women are more likely to have a post-surgery emergency department visit within 90 days than non-Hispanic white women, a USC study found.
The ABAT enzyme helps cancerous medulloblastoma cells feed and survive, according to a study led by the USC Brain Tumor Center and the Norris Comprehensive Cancer Center.
These findings by USC researchers could help health care providers and genetic counselors offer more precision-based care and advice, particularly in the multiethnic populations of L.A. County.
HUBs will enhance community engagement and provide a local resource for cancer-related education and navigation support for cancer services.
You might find a hangover cure, protection against Alzheimer’s and much more in nature’s bounty.
USC physician-scientists look for promising treatments for colorectal cancer on a postage stamp-size chip.
A nationally recognized leader in cancer prevention and minority health research, she has dedicated her career to reducing the disparities in cancer outcomes that affect patients from underrepresented communities.
Peter Kuhn of the USC Michelson Center for Convergent Bioscience will serve as deputy director of a new virtual cancer center, funded by a grant from the Department of Defense.
A decade after surviving lymphoma as a child, a young woman gets critical guidance from a USC doctor about her fertility.
Dedicated space for the Convergent Science Institute in Cancer initiative aims to get biologists, physicists and chemists collaborating on cutting-edge ideas that benefit patients.
Tracking the physical activity levels of people receiving chemotherapy can improve their care and even predict emergency room visits, according to USC research.
Sophie Mansfield started out as a high school student in a special program at the Lawrence J. Ellison Institute for Transformative Medicine of USC. Learn how the USC graduate now works equity in cancer care.
The research — co-led by the USC Norris Comprehensive Cancer Center — identified 86 new genetic variations that increase the risk of prostate cancer.